Anemia in myelofibrosis significantly affects survival and quality of life, with severe anemia reducing median survival ...

Studies show patients with chronic kidney disease (CKD) and COVID-19 are at increased risk for an intensive care unit stay and early death. Anemia is an extra risk factor.

For patients with myelofibrosis who had anemia at diagnosis and received erythropoiesis-stimulating agents (ESAs) or danazol ...